Rigel Pharmaceuticals, Inc.
Benzazole compounds and methods for making and using the compounds
Last updated:
Abstract:
Disclosed are novel benzazole compounds and compositions comprising the compounds. The compounds are useful as kinase inhibitors including interleukin receptor associated kinases (IRAK) inhibitors. Also disclosed are methods of making and using the compounds and compositions. The disclosed compounds and/or compositions may be used to treat or prevent an IRAK-associated disease or condition.
Status:
Grant
Type:
Utility
Filling date:
14 Jul 2020
Issue date:
12 Apr 2022